Repression of hepatitis B viral gene expression by transcription factor nuclear factor-kappaB

Cellular Microbiology

Volumn 11, Issue 4, 2009, Pages 645-660

  Lin, Yen Cheng ^a   Hsu, En Chi ^a   Ting, Ling Pai ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; SMALL INTERFERING RNA; SYNAPTOTAGMIN I;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CONTROLLED STUDY; EMBRYO; GENE DELETION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; REPORTER GENE; TRANSCRIPTION INITIATION; VIRUS GENE; VIRUS REPLICATION;

CELL LINE; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, VIRAL; GENE SILENCING; GENES, IMMEDIATE-EARLY; HEPATITIS B VIRUS; HUMANS; IMMEDIATE-EARLY PROTEINS; NF-KAPPA B; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION; VIRAL PROTEINS;

HEPATITIS B VIRUS;

EID: 62149152072     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2008.01280.x     Document Type: Article

References (56)

1. Baumert, T.F., Thimme, R., and von Weizsacker, F. (2007) Pathogenesis of hepatitis B virus infection. World J Gastroenterol 13: 82-90.
2. Bertoletti, A., and Gehring, A.J. (2006) The immune response during hepatitis B virus infection. J Gen Virol 87: 1439-1449.
3. Biermer, M., Puro, R., and Schneider, R.J. (2003) Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB. J Virol 77: 4033-4042.
4. Block, T.M., Mehta, A.S., Fimmel, C.J., and Jordan, R. (2003) Molecular viral oncology of hepatocellular carcinoma. Oncogene 22: 5093-5107.
5. Brunetto, M.R., Giarin, M.M., Oliveri, F., Chiaberge, E., Baldi, M., Alfarano, A., et al. (1991) Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci USA 88: 4186-4190.
6. Chen, I.H., Huang, C.J., and Ting, L.P. (1995) Overlapping initiator and TATA box functions in the basal core promoter of hepatitis B virus. J Virol 69: 3647-3657.
7. De Bosscher, K., Vanden Berghe, W., and Haegeman, G. (2006) Cross-talk between nuclear receptors and nuclear factor κB. Oncogene 25: 6868-6886.
8. Ganem, D., and Prince, A.M. (2004) Hepatitis B virus infection - natural history and clinical consequences. N Engl J Med 350: 1118-1129.
9. Gilmore, T.D. (2006) Introduction to NF-kappaB: Players, pathways, perspectives. Oncogene 25: 6680-6684.
10. Gray, S., and Levine, M. (1996) Transcriptional repression in development. Curr Opin Cell Biol 8: 358-364.
11. Guidotti, L.G., and Chisari, F.V. (2001) Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 19: 65-91.
12. Guidotti, L.G., and Chisari, F.V. (2006) Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol 1: 23-61.
13. Hanna-Rose, W., and Hansen, U. (1996) Active repression mechanisms of eukaryotic transcription repressors. Trends Genet 12: 229-234.
14. Hayden, M.S., and Ghosh, S. (2004) Signaling to NF-kappaB. Genes Dev 18: 2195-2224.
15. Heise, T., Guidotti, L.G., and Chisari, F.V. (1999) La autoantigen specifically recognizes a predicted stem-loop in hepatitis B virus RNA. J Virol 73: 5767-5776.
16. Heise, T., Guidotti, L.G., and Chisari, F.V. (2001) Characterization of nuclear RNases that cleave hepatitis B virus RNA near the La protein binding site. J Virol 75: 6874-6883.
17. Hiscott, J., Nguyen, T.L., Arguello, M., Nakhaei, P., and Paz, S. (2006) Manipulation of the nuclear factor-kappaB pathway and the innate immune response by viruses. Oncogene 25: 6844-6867.
18. Hoffmann, A., Natoli, G., and Ghosh, G. (2006) Transcriptional regulation via the NF-kappaB signaling module. Oncogene 25: 6706-6716.
19. Hu, Z., Zhang, Z., Doo, E., Coux, O., Goldberg, A.L., and Liang, T.J. (1999) Hepatitis B virus X protein in both a substrate and a potential inhibitor of the proteasome complex. J Virol 73: 7231-7240.
20. Huang, C.J., Chen, Y.H., and Ting, L.P. (2000) Hepatitis B virus core protein interacts with the C-terminal region of actin-binding protein. J Biomed Sci 7: 160-168.
21. Huxford, T., Malek, S., and Ghosh, G. (1999) Structure and mechanism in NF-kappa B/I kappa B signaling. Cold Spring Harb Symp Quant Biol 64: 533-540.
22. Kuo, Y.L., and Ting, L.P. (1997) Differential regulation of major surface promoter in hepatitis B virus. DNA Cell Biol 16: 545-557.
23. Kwon, J.A., and Rho, H.M. (2002) Hepatitis B viral core protein activates the hepatitis B viral enhancer II/pregenomic promoter through the nuclear factor kappaB binding site. Biochem Cell Biol 80: 445-455.
24. Lai, C.K., and Ting, L.P. (1999) Transcriptional repression of human hepatitis B virus genes by a bZIP family member, E4BP4. J Virol 73: 3197-3209.
25. Levine, M., and Manley, J.L. (1989) Transcriptional repression of eukaryotic promoters. Cell 59: 405-408.
26. Li, J., and Ou, J.H. (2001) Differential regulation of hepatitis B virus gene expression by the Sp1 transcription factor. J Virol 75: 8400-8406.
27. Lin, S., Wu, M., Xu, Y., Xiong, W., Yi, Z., Zhang, X., and Yuan, Z. (2007) Inhibition of hepatitis B virus replication by MyD88 is mediated by nuclear factor-kappaB activation. Biochim Biophys Acta 1772: 1150-1157.
28. Liu, W.K., Yen, P.F., Chien, C.Y., Fann, M.J., Su, J.Y., and Chou, C.K. (2004) The inhibitor ABIN-2 disrupts the interaction of receptor-interacting protein with the kinase subunit IKKgamma to block activation of the transcription factor NF-kappaB and potentiate apoptosis. Biochem J 378: 867-876.
29. Muller, M., Morotti, A., and Ponzetto, C. (2002) Activation of NF-kappaB is essential for hepatocyte growth factor-mediated proliferation and tubulogenesis. Mol Cell Biol 22: 1060-1072.
30. Perkins, N.D. (2006) Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 25: 6717-6730.
31. Perkins, N.D., Agranoff, A.B., Pascal, E., and Nabel, G.J. (1994) An interaction between the DNA-binding domains of RelA (p65) and Sp1 mediates human immunodeficiency virus gene activation. Mol Cell Biol 14: 6570-6583.
32. Pikarsky, E., Porat, R.M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., et al. (2004) NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431: 461-466.
33. Puro, R., and Schneider, R.J. (2007) Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA. J Virol 81: 7351-7362.
34. Raney, A.K., and McLachlan, A. (1992) Regulation of transcription from the hepatitis B virus major surface antigen promoter by the Sp1 transcription factor. J Virol 66: 6912-6921.
35. Raney, A.K., and McLachlan, A. (1995) Characterization of the hepatitis B virus large surface antigen promoter Sp1 binding site. Virology 208: 399-404.
36. Reignat, S., Webster, G.J., Brown, D., Ogg, G.S., King, A., Seneviratne, S.L., et al. (2002) Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J Exp Med 195: 1089-1101.
37. Robek, M.D., Wieland, S.F., and Chisari, F.V. (2002) Inhibition of hepatitis B virus replication by interferon requires proteasome activity. J Virol 76: 3570-3574.
38. Robek, M.D., Garcia, M.L., Boyd, B.S., and Chisari, F.V. (2007) Role of immunoproteasome catalytic subunits in the immune response to hepatitis B virus. J Virol 81: 483-491.
39. Santoro, M.G., Rossi, A., and Amici, C. (2003) NF-kappaB and virus infection: Who controls whom. EMBO J 22: 2552-2560.
40. Schoemaker, M.H., Ros, J.E., Homan, M., Trautwein, C., Liston, P., Poelstra, K., et al. (2002) Cytokine regulation of pro- and anti-apoptotic genes in rat hepatocytes: NF-kappaB-regulated inhibitor of apoptosis protein 2 (cIAP2) prevents apoptosis. J Hepatol 36: 742-750.
41. Schwabe, R.F., and Brenner, D.A. (2006) TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol 290: G583-G589.
42. Seeger, C., and Mason, W.S. (2000) Hepatitis B virus biology. Microbiol Mol Biol Rev 64: 51-68.
43. Su, F., and Schneider, R.J. (1996) Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins. J Virol 70: 4558-4566.
44. Suske, G. (1999) The Sp-family of transcription factors. Gene 238: 291-300.
45. Tao, Y., Kassatly, K.R., Cress, W.D., and Horowitz, J.M. (1997) Subunit composition determines E2F DNA-binding site specificity. Mol Cell Biol 17: 6994-7007.
46. Thimme, R., Wieland, S., Steiger, C., Ghrayeb, J., Reimann, K.A., Purcell, R.H., and Chisari, F.V. (2003) CD8 (+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 77: 68-76.
47. Thut, C.J., Goodrich, J.A., and Tjian, R. (1997) Repression of p53-mediated transcription by MDM2: A dual mechanism. Genes Dev 11: 1974-1986.
48. Tur-Kaspa, R., Shaul, Y., Moore, D.D., Burk, R.D., Okret, S., Poellinger, L., and Shafritz, D.A. (1988) The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer. Virol 167: 630-633.
49. Webster, G.J., Reignat, S., Brown, D., Ogg, G.S., Jones, L., Seneviratne, S.L., et al. (2004) Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: Implications for immunotherapy. J Virol 78: 5707-5719.
50. Wieland, S., Thimme, R., Purcell, R.H., and Chisari, F.V. (2004) Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci USA 101: 6669-6674.
51. Wieland, S.F., and Chisari, F.V. (2005) Stealth and cunning: Hepatitis B and hepatitis C viruses. J Virol 79: 9369-9380.
52. Wieland, S.F., Eustaquio, A., Whitten-Bauer, C., Boyd, B., and Chisari, F.V. (2005) Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids. Proc Natl Acad Sci USA 102: 9913-9917.
53. Xiong, W., Wang, X., Liu, X., Xiang, L., Zheng, L., and Yuan, Z. (2004) Interferon-inducible MyD88 protein inhibits hepatitis B virus replication. Virol 319: 306-314.
54. Yang, C.Y., Kuo, T.H., and Ting, L.P. (2006) Human hepatitis B viral e antigen interacts with cellular interleukin-1 receptor accessory protein and triggers interleukin-1 response. J Biol Chem 281: 34525-34536.
55. Yuh, C.H., Chang, Y.L., and Ting, L.P. (1992) Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus. J Virol 66: 4073-4084.
56. Zhang, P., Raney, A.K., and McLachlan, A. (1993) Characterization of functional Sp1 transcription factor binding sites in the hepatitis B virus nucleocapsid promoter. J Virol 67: 1472-1481.